Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0507 per EA under NDC 76282071430. Its NADAC has been published 111 times since Oct 9, 2024.

FDA first approved this application on Sep 15, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0507per EA

Strength

800 mg/1

NDC

76282071430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA091625

FDA Approved

9/15/2015

TE Code

AB

On Market Since

3/10/2022

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 111 times since Oct 9, 2024, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0507 per EA
All-time high$0.0641 (Oct 16, 2024)
All-time low$0.0507 (Nov 18, 2026)
52-week high$0.0585
52-week low$0.0507
Median price$0.0570
Average price$0.0580
Largest weekly change-17.8% (Nov 20, 2024)
Weeks tracked111
Tracking sinceOct 9, 2024

Price History

1W

-8.6%

1M

-11.4%

3M

-13.3%

6M

-10.6%

1Y

-11.0%

3Y

N/A

5Y

N/A

All

-20.8%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0507 per EA (NDC 76282071430), effective Nov 18, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 20.8%. It has been tracked across 111 weekly CMS publications since Oct 9, 2024.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Oct 9, 2024, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0507 (Nov 18, 2026) to a high of $0.0641 (Oct 16, 2024), with a median of $0.0570 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 76282071430) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.